Compare UI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UI | RVMD |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United States |
| Employees | N/A | 883 |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.1B | 30.1B |
| IPO Year | 2011 | N/A |
| Metric | UI | RVMD |
|---|---|---|
| Price | $523.98 | $186.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 19 |
| Target Price | ★ $753.50 | $140.84 |
| AVG Volume (30 Days) | 102.7K | ★ 2.9M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.33% | N/A |
| EPS Growth | ★ 103.11 | N/A |
| EPS | ★ 11.15 | N/A |
| Revenue | ★ $2,573,545,000.00 | N/A |
| Revenue This Year | $32.66 | N/A |
| Revenue Next Year | $16.11 | $533.02 |
| P/E Ratio | $47.21 | ★ N/A |
| Revenue Growth | ★ 33.45 | N/A |
| 52 Week Low | $380.00 | $34.00 |
| 52 Week High | $1,099.99 | $193.10 |
| Indicator | UI | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.22 | 72.65 |
| Support Level | N/A | $93.39 |
| Resistance Level | $592.39 | N/A |
| Average True Range (ATR) | 24.13 | 7.30 |
| MACD | 4.98 | 2.52 |
| Stochastic Oscillator | 8.47 | 91.72 |
Ubiquiti Inc is a seller of equipment and provides the related software platforms through web stores. The group develops technology platforms for high-capacity distributed Internet access, unified information technology, and consumer electronics for professional, home, and personal use. Its solutions are: high-performance networking technology for enterprises, service providers, and consumers. target the enterprise and service provider markets through a community of service providers, distributors, value-added resellers, webstores, systems integrators, and corporate IT professionals, which it refers to as the Ubiquiti Community. It targets consumers through digital marketing, including through webstores, retail chains, and, to a lesser extent, the Ubiquiti Community.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.